This award goes to the company or partnership that has developed a market-leading product that, through excellence in research, development and/or manufacturing, has resulted in the launch of an exciting and innovative new offering in the bio/pharmaceutical sector that combines innovative science or product features in a way that demonstrates substantial benefits to patient populations when compared with existing therapeutics available for that disease condition.

Judging criteria:

• Novel targeting

• Combination therapies

• Route of administration

• Delivery technologies

• Companion diagnostics

Back to Awards